SynthesisJournal of orthopaedic surgery and research2026
Efficacy and safety of ketamine in total hip arthroplasty: a systematic review.
Synthesis in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundTotal hip arthroplasty (THA) is a common procedure for end-stage hip disorders, yet optimal perioperative pain management remains challenging. Ketamine and its S-enantiomer, esketamine, have been proposed as adjuncts in multimodal analgesia due to their opioid-sparing effects and unique mechanisms. However, existing evidence on their efficacy and safety in THA patients is conflicting and has not been systematically reviewed.
methodsA systematic search of PubMed, Cochrane Library, EMBASE, and Web of Science was conducted from inception to February 2026. Studies were included if they involved THA patients receiving perioperative ketamine or esketamine and reported outcomes related to pain, opioid use, delirium, functional recovery, or adverse events. Quality was assessed using the Cochrane Risk of Bias 2 (RoB 2) tool for randomized controlled trials and the Newcastle-Ottawa Scale (NOS) for cohort studies.
resultsThirteen studies (10 RCTs, 3 cohort studies) encompassing 693,978 patients were included. Although several studies reported reductions in postoperative pain scores and opioid consumption, as well as improvements in early functional recovery and emotional status, these findings were not universal, and heterogeneity across study protocols precludes definitive conclusions. Findings on postoperative delirium were conflicting: one large RCT reported a significant reduction, while a retrospective study suggested increased risk with ketamine use. No serious adverse events were reported; however, psychotomimetic effects such as hallucinations and nightmares were more common in some ketamine groups compared to controls.
conclusionsPerioperative ketamine may offer benefits in analgesia, opioid sparing, and functional recovery after THA, but its effects on delirium are inconsistent and may depend on dosing and patient characteristics. Individualized administration and cautious use in high-risk elderly patients may be considered, though further research is needed to clarify optimal protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.